Terns Pharmaceuticals (TERN) PT Raised at BMO Capital on 'Strong ASH Data'
Tweet Send to a Friend
BMO Capital analyst Evan David Seigerman raised the price target on Terns Pharmaceuticals (NASDAQ: TERN) to $22.00 (from $15.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
